David A. Gass

Dr. David A. Gass

Hematology | Oncology
1001 Blythe Blvd., Suite 3000, 
Charlotte, NC 
On Staff At
Accepting New Patients
Offers Telehealth
1001 Blythe Blvd., Suite 3000, 
Charlotte, NC 
OverviewInsuranceLocationsClinical Research

Overview

David Gass is a Hematologist and an Oncologist in Charlotte, North Carolina. Dr. Gass is rated as an Experienced provider by MediFind in the treatment of Hereditary Pyropoikilocytosis. His top areas of expertise are Brain Tumor, Brain Stem Cancer, Agranulocytosis, and Glioma. Dr. Gass is currently accepting new patients.

His clinical research consists of co-authoring 9 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.

Graduate Institution
State University Of New York At Buffalo
Residency
New York University, Pediatric Residency
Specialties
Hematology
Oncology
Licenses
Pediatric Hematology-Oncology in NC
Board Certifications
American Board Of Pediatrics
Fellowships
Cincinnati Children's Hospital Medical Center, Pediatric Neuro-Oncology
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

Atrium Health Levine Children’s Cancer & Blood Disorders, a facility of Carolinas Medical Center
1001 Blythe Blvd., Suite 3000, Charlotte, NC 28203

Additional Areas of Focus

Dr. Gass has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Immune Thrombocytopenic Purpura (ITP)
Brain Tumor
Sickle Cell Disease
Anemia
Leukemia
Neurofibromatosis Type 1 (NF1)
Neuroblastoma

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Use Of A Response-Adapted Ruxolitinib-Containing Regimen For The Treatment Of Hemophagocytic Lymphohistiocytosis
Use Of A Response-Adapted Ruxolitinib-Containing Regimen For The Treatment Of Hemophagocytic Lymphohistiocytosis
Enrollment Status: Active_not_recruiting
Publish Date: December 15, 2025
Intervention Type: Drug
Study Drugs: Ruxolitinib, Dexamethasone, Etoposide
Study Phase: Phase 1/Phase 2

9 Total Publications

Clinical and biological landscape of constitutional mismatch-repair deficiency syndrome: an International Replication Repair Deficiency Consortium cohort study.
Clinical and biological landscape of constitutional mismatch-repair deficiency syndrome: an International Replication Repair Deficiency Consortium cohort study.
Journal: The Lancet. Oncology
Published: August 28, 2023

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Gass's expertise for a condition
ConditionClose
        View All 21 Experienced Conditions
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile